ReviewCurrent opinion in microbiology2026
Innate immune responses to Rickettsia: emerging themes and contrasts between species.
Review in Current opinion in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Detection and Phylogenetic Analysis of Vector-Borne Pathogens fromVeterinary sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Over 10 species of Rickettsia cause serious human disease across the globe, including deadly spotted fever and typhus. These arthropod-borne microbes and their close relatives are the only bacteria that obligately reside in the eukaryotic cytosol, making them distinctive tools to study innate immunity. Yet, the molecular details on how Rickettsia species interact with innate immunity have remained largely enigmatic. Recent advances are revealing that Rickettsia species are not only distinct from other bacterial pathogens that reside in the cytosol, but in some cases, they are highly distinct from one another in how they manipulate mammalian immune pathways. Here, we review an emerging paradigm that detection of Rickettsia species by inflammasomes appears largely conserved, whereby the pathogenic species largely evade inflammasomes, yet subpopulations can be detected after infrequent bacteriolysis. In contrast, different Rickettsia species have highly unique interactions with antibacterial autophagy (xenophagy), whereby some species evolved sophisticated mechanisms to avoid ubiquitylation, whereas others co-opt xenophagy to their benefit. Lastly, we review emerging literature regarding the role of immune cells in infection, which are increasingly appreciated as major targets in vivo. These insights set the stage for an exciting era of leveraging Rickettsia as powerful microbial tools to unravel how cytosolic pathogens subvert mammalian innate immune systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.